Results for the other subgroups generally showed a trend in favor of galantamine, regardless of age, MMSE values, or DAD values at baseline (Fig. 1 ).
← all excerpts
Effect of concomitant use of memantine on mortality and efficacy outcomes of galantamine-treated patients with Alzheimer's disease: post-hoc analysis of a randomized placebo-controlled study.
1
—
—